NEXENTIS TECHNOLOGIES INC. Payments to Acquire Interest in Subsidiaries and Affiliates
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Payments to Acquire Interest in Subsidiaries and Affiliates of $7.57 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInSubsidiariesAndAffiliates · last filed 2020-03-30
- NEXENTIS TECHNOLOGIES INC. payments to acquire interest in subsidiaries and affiliates for fiscal 2019 was $7.57K.
| Period end | Payments to Acquire Interest in Subsidiaries and Affiliates 12 month |
|---|---|
| 2019-12-31 | $7.57K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |